-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
August 01, 2012 - What are the significant safety concerns associated
with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated
with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated
with each treatment strategy (i.e., adverse drug … Outcomes and effect
modifiers
• Primary outcomes: major adverse cardiovascular
events such as death … • Adverse effects of interventions: adverse
drug reactions, radiation exposure, access site
complications
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-survivor-care-transition_research-protocol.pdf
March 27, 2013 - , detection, surveillance, or treatment services.6 This fragmentation of care may have
significant adverse … • Adverse … • Mortality
• Quality of life
• Satisfaction with care
• Cost and resource utilization
• Adverse … events
• Outcomes attributable to the cancer
treatment (except for adverse
events and other long-term … It
seeks to both prevent and control adverse cancer diagnosis and treatment-related outcomes such
as
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
December 17, 2013 - available, people with MS may
switch between different medications depending on tolerance, presence of adverse … Adverse effects of intervention(s)
□ Any reported adverse events
! … treatment and followup duration or have indeterminable
numerators and denominators for outcomes and adverse … participant baseline demographics; type of CIS or MS, MS severity; descriptions and
results of outcomes and adverse … Lehmann-Horn K, et
al., Current treatment strategies for multiple
sclerosis—Efficacy versus neurological
adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
December 01, 2012 - Titles and abstracts were screened in duplicate for studies
that looked at overall survival, adverse … Harms included
specific negative effects, including the narrower definition
of adverse effects. … Other adverse events are
listed in Table 9 of the full report. … SBRT Insufficient One study reported no major complications.69 Other adverse events are reported in … Lack of experience may not only affect patient
outcomes but also result in adverse effects; patients
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - RCT found no
November 2011
In 1 new RCT, 100%
of tx and 97% of
controls reported at
least one adverse … Stalvey, 201124 See above Adverse events
associated with rhGH
treatment of CF
patients
100% … of tx and
97% of controls
reported at least
one adverse event
(AE). 12
participants in each
group … Key Question 6: In patients with CF, how are efficacy, effectiveness, safety, or adverse events impacted … Key Question 6: In patients with CF, how are efficacy, effectiveness, safety, or adverse events impacted
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
August 22, 2008 - KQ 4: In patients with CF, what is the frequency of nonmalignant serious adverse effects
resulting from … Adverse effects of interest include,
but are not limited to: glucose intolerance, diabetes, and hypoglycemia … KQ 6: In patients with CF, how is efficacy, effectiveness, safety or adverse events impacted
by rhGH … KQ 7: In patients with CF, how do the efficacy, effectiveness, safety or adverse events of
treatment … Important health outcomes in KQ2 and adverse events in KQ4 associated with rhGH will be
meta-analyzed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
January 27, 2012 - KQ3a: What adverse effects are associated with
medications for adults with AUDs in outpatient
settings … KQ 3b: How do medications for adults with AUDs
compare for adverse effects in outpatient settings? … Evidence for many potential adverse events was
insufficient to determine whether the risk was increased … For most of the specific adverse events, point estimates
favored placebo (i.e., there were more adverse … In head-to-head studies, the risk of withdrawal
due to adverse events was not significantly different
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
January 01, 2009 - diet including the use of medical foods, amino
acids, and micronutrients supplement
Outcomes: Cost, adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0288_03-10-2008.pdf
January 01, 2008 - The efficacy of home uterine activity monitoring in decreasing adverse outcomes in women
who are experiencing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
December 01, 2011 - It seems unusual to present a reduced incidence of
an adverse effect with an NNT. … Peer Reviewer #5 Results KQ4 Page 123 or page 108, line 44
Adverse Events and Discontinuation Rates: … events such as
suicidality, seizures, cardiovascular adverse events, serotonin
syndrome, hyponatremia … This is reflected in the differential adverse
effect profile of somnolence with mirtazapine. … We included this study in KQ4 on adverse
events
Peer Reviewer #3 Introduction Table 5.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
June 05, 2013 - ES-8: please clarify SOE for long-term adverse events
(insufficient?)
Yes, insufficient. … If so, we discuss adverse events
associated with medications. … Peer Reviewer 2 Future
Research
p. 48, adverse events: please specify the SOE for long term
adverse … Please specify the SOE for short-
term adverse events (moderate). … SOE is insufficient for long term, low for short term
adverse events.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - Although some experts believe the risk of
adverse events would affect patient and clinician adoption … No serious adverse events were reported. … -
emergent adverse events were reported most frequently, but were seldom treatment
limiting. … The incidence of serious adverse events potentially related to systemic vascular
endothelial growth … Rate
of serious adverse effects in a series of
bevacizumab and ranibizumab injections.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-200-comments-post-acs.pdf
November 14, 2017 - Second, the
analytic framework has 'adverse effects' as a box, but
without either a key question or … This should be added, and a discussion of the
adverse effects found, if any, should be added to the … A
discussion of the adverse outcomes
are included in the detailed findings
of the report and is one … Peer Reviewer #1 Results Results should add one section on adverse events/harm
for both KQ1 and KQ2. … Noncardiac adverse effects were
reported in only one study.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
June 24, 2014 - What adverse events and complications have been associated with
aggressive medical therapy or renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
December 23, 2014 - What are the adverse outcomes of untreated infantile hemangiomas? … blocker[tiab] OR beta-blockers[tiab] OR angiotensin[tiab] OR intralesional
interferon[tiab] OR “adverse … event[tiab] OR undesirable events[tiab]
OR undesirable outcome[tiab] OR undesirable outcomes[tiab] OR adverse … effect[tiab] OR adverse effects[tiab] OR adverse reaction[tiab] OR adverse
reactions[tiab] OR adverse … event[tiab] OR adverse events[tiab] OR adverse
outcome[tiab] OR adverse outcomes[tiab] OR "Postoperative
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
March 01, 2015 - What are the
significant agent-specific harms/adverse effects of
nonhormone therapies? … Do effectiveness and adverse effects
vary among subgroups of participants defined by
demographics, … Key Question 3 was
a two-part question examining adverse events and long-
term effects of nonhormone … For the adverse
events question, trials included in Key Question 1 that also
reported adverse events … Agent-specific adverse events for nonhormone therapies
were categorized using a system recommended by
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
July 01, 2012 - continuous positive
airway pressure (CPAP), associated with less morbidity,
lower mortality, fewer adverse … In general, the figure shows that this CER compares
morbidity, mortality, adverse events, and health … Adverse events considered are
aspiration, secondary infections (including pneumonia
and sinusitis), … The safety outcomes were framed to help identify
adverse events, including hospital-acquired pneumonia … We included common
outcomes of interest such as mortality and adverse events,
but also examined more
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
April 02, 2015 - are benefits of very long chain polyunsaturated fatty
acids (EPA and DHA) for reducing the risk of adverse … Adverse events:
• What adverse effects are related to n-3 FA intake or biomarker concentrations
( … • What adverse events are reported specifically among people with CVD or
diabetes (in studies of CVD … • Exclude n-3 FA dose ≥6 g/day (except for adverse events)
Source: www.effectivehealthcare.ahrq.gov … density lipoprotein cholesterol [LDL-c], total/HDL-c ratio, LDL-c/HDL-c
ratio, triglycerides)
• Adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
June 01, 2012 - What adverse events and complications have been associated with aggressive
medical therapy or renal … No Signal
Adverse events:
Consistent to the original CER, the adverse events were not adequately assessed … What adverse events and complications have been associated with aggressive medical therapy or renal artery … Adverse events
The evidence does not adequately
assess comparisons of adverse events
between medical … These adverse events occurred at
different centers and with
Different providers.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
October 01, 2016 - One RCT43 examined three possible harms: drug-related
adverse effects; incidence of abnormal QT (QRS … midazolam vs. a combination of
droperidol plus midazolam (3 vs. 1
vs. 2, p=NR).43
Adverse
effects … flunitrazepam, no statistical testing
reported (3 vs. 3, p=NR).48
Drug-related
adverse events
91 … other medication
protocols
(continued)
Adverse
effects from
medication
(continued)
Reduction in … events with olanzapine
vs. risperidone vs. haloperidol,
p=NR.72
Adverse events
considered
related